Search

BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2943-2959
Author(s): F. Leonetti, A. Stefanachi, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare, A. Carotti

Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)

Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116

A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 5294-5318
Author(s): P. Robak, T. Robak

Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives

Journal: Current Biotechnology
Volume: 1 Issue: 2 Year: 2012 Page: 175-183
Author(s): Min Shen,Q. Ping Dou

Recent Advances in Drug Repurposing for Parkinson’s Disease

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 28 Year: 2019 Page: 5340-5362
Author(s): Xin Chen,Giuseppe Gumina,Kristopher G. Virga

Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2836-2847
Author(s): E. Crespan, E. Zucca, G. Maga

Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia

Journal: Current Medicinal Chemistry
Volume: 25 Issue: 24 Year: 2018 Page: 2811-2825
Author(s): Raffaella Franca,Natasa K. Kuzelicki,Claudio Sorio,Eleonora Toffoletti,Oksana Montecchini,Alice Poropat,Marco Rabusin,Debora Curci,Dino Paladin,Gabriele Stocco,Giuliana Decorti

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17 Issue: 1 Year: 2018 Page: 14-21
Author(s): Abdelrahman Ibrahim Abushouk,Ahmed Negida,Rasha Abdelsalam Elshenawy,Hossam Zein,Ali M. Hammad,Ahmed Menshawy,Wael M.Y. Mohamed

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 120-133
Author(s): Bernhard A. Muller

Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 1 Year: 2013 Page: 69-79
Author(s): J. Kuroda,Y. Shimura,M. Yamamoto-Sugitani,N. Sasaki,M. Taniwaki